nodes	percent_of_prediction	percent_of_DWPC	metapath
Flunarizine—CALM1—autonomic nervous system—conduct disorder	0.147	0.377	CbGeAlD
Flunarizine—Fluspirilene—SLC6A4—conduct disorder	0.0865	0.427	CrCbGaD
Flunarizine—Fluspirilene—HTR2A—conduct disorder	0.0665	0.328	CrCbGaD
Flunarizine—CACNA1I—brain—conduct disorder	0.0637	0.163	CbGeAlD
Flunarizine—Pimozide—HTR2A—conduct disorder	0.0497	0.245	CrCbGaD
Flunarizine—CACNA1G—brain—conduct disorder	0.0437	0.112	CbGeAlD
Flunarizine—CACNA1H—brain—conduct disorder	0.0286	0.073	CbGeAlD
Flunarizine—CYP2A6—brain—conduct disorder	0.0211	0.054	CbGeAlD
Flunarizine—CALM3—brain—conduct disorder	0.0182	0.0466	CbGeAlD
Flunarizine—CALM2—brain—conduct disorder	0.0143	0.0366	CbGeAlD
Flunarizine—CALM1—brain—conduct disorder	0.0142	0.0364	CbGeAlD
Flunarizine—CYP1A2—Methylation—COMT—conduct disorder	0.013	0.032	CbGpPWpGaD
Flunarizine—CYP1A1—Estrogen metabolism—COMT—conduct disorder	0.0127	0.0314	CbGpPWpGaD
Flunarizine—HRH1—Monoamine GPCRs—DRD4—conduct disorder	0.0123	0.0303	CbGpPWpGaD
Flunarizine—CYP1A1—brain—conduct disorder	0.011	0.028	CbGeAlD
Flunarizine—CYP2B6—brain—conduct disorder	0.0106	0.0272	CbGeAlD
Flunarizine—HRH1—brain—conduct disorder	0.0104	0.0266	CbGeAlD
Flunarizine—HRH1—Amine ligand-binding receptors—DRD4—conduct disorder	0.0104	0.0255	CbGpPWpGaD
Flunarizine—CALM1—Melatonin metabolism and effects—MAOA—conduct disorder	0.0088	0.0217	CbGpPWpGaD
Flunarizine—CALM2—Melatonin metabolism and effects—MAOA—conduct disorder	0.0088	0.0217	CbGpPWpGaD
Flunarizine—CYP1A1—Melatonin metabolism and effects—MAOA—conduct disorder	0.00864	0.0213	CbGpPWpGaD
Flunarizine—CYP1A1—Oxidative Stress—MAOA—conduct disorder	0.0084	0.0207	CbGpPWpGaD
Flunarizine—CYP1A2—Estrogen metabolism—COMT—conduct disorder	0.00812	0.02	CbGpPWpGaD
Flunarizine—HRH1—Monoamine GPCRs—HTR2A—conduct disorder	0.00804	0.0198	CbGpPWpGaD
Flunarizine—CYP2D6—brain—conduct disorder	0.00791	0.0202	CbGeAlD
Flunarizine—HRH1—Amine ligand-binding receptors—HTR2A—conduct disorder	0.00676	0.0166	CbGpPWpGaD
Flunarizine—CACNA1G—Regulation of nuclear beta catenin signaling and target gene transcription—EP300—conduct disorder	0.00676	0.0166	CbGpPWpGaD
Flunarizine—CYP2D6—Melatonin metabolism and effects—MAOA—conduct disorder	0.0065	0.016	CbGpPWpGaD
Flunarizine—CALM3—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00573	0.0141	CbGpPWpGaD
Flunarizine—CALM1—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00554	0.0136	CbGpPWpGaD
Flunarizine—CALM2—VEGFA-VEGFR2 Pathway—WASF1—conduct disorder	0.00554	0.0136	CbGpPWpGaD
Flunarizine—CYP1A2—Melatonin metabolism and effects—MAOA—conduct disorder	0.00551	0.0136	CbGpPWpGaD
Flunarizine—CALM3—Signaling by VEGF—WASF1—conduct disorder	0.00541	0.0133	CbGpPWpGaD
Flunarizine—CALM3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.0054	0.0133	CbGpPWpGaD
Flunarizine—CYP2A6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00525	0.0129	CbGpPWpGaD
Flunarizine—CALM2—Signaling by VEGF—WASF1—conduct disorder	0.00523	0.0129	CbGpPWpGaD
Flunarizine—CALM1—Signaling by VEGF—WASF1—conduct disorder	0.00523	0.0129	CbGpPWpGaD
Flunarizine—CALM2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00523	0.0129	CbGpPWpGaD
Flunarizine—CALM1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GABRA2—conduct disorder	0.00523	0.0129	CbGpPWpGaD
Flunarizine—CYP2B6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00424	0.0104	CbGpPWpGaD
Flunarizine—CYP2A6—NRF2 pathway—SLC6A4—conduct disorder	0.00423	0.0104	CbGpPWpGaD
Flunarizine—CALM3—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00406	0.01	CbGpPWpGaD
Flunarizine—CALM1—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00393	0.00968	CbGpPWpGaD
Flunarizine—CALM2—Transmission across Chemical Synapses—GABRA2—conduct disorder	0.00393	0.00968	CbGpPWpGaD
Flunarizine—CYP1A1—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00391	0.00963	CbGpPWpGaD
Flunarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—CGA—conduct disorder	0.00364	0.00896	CbGpPWpGaD
Flunarizine—CALM3—Neuronal System—GABRA2—conduct disorder	0.00311	0.00766	CbGpPWpGaD
Flunarizine—CALM2—Neuronal System—GABRA2—conduct disorder	0.00301	0.00741	CbGpPWpGaD
Flunarizine—CALM1—Neuronal System—GABRA2—conduct disorder	0.00301	0.00741	CbGpPWpGaD
Flunarizine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00295	0.00725	CbGpPWpGaD
Flunarizine—CYP2C9—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.00292	0.00719	CbGpPWpGaD
Flunarizine—HRH1—IL-4 Signaling Pathway—EP300—conduct disorder	0.00287	0.00707	CbGpPWpGaD
Flunarizine—CALM3—IFN-gamma pathway—EP300—conduct disorder	0.00287	0.00706	CbGpPWpGaD
Flunarizine—CYP2A6—Biological oxidations—COMT—conduct disorder	0.00281	0.00692	CbGpPWpGaD
Flunarizine—CYP2A6—Biological oxidations—MAOA—conduct disorder	0.00279	0.00687	CbGpPWpGaD
Flunarizine—CALM1—IFN-gamma pathway—EP300—conduct disorder	0.00277	0.00683	CbGpPWpGaD
Flunarizine—CALM2—IFN-gamma pathway—EP300—conduct disorder	0.00277	0.00683	CbGpPWpGaD
Flunarizine—HRH1—GPCR ligand binding—CGA—conduct disorder	0.00277	0.00682	CbGpPWpGaD
Flunarizine—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00258	0.00635	CbGpPWpGaD
Flunarizine—CYP1A1—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00258	0.00635	CbGpPWpGaD
Flunarizine—CYP1A2—Phase 1 - Functionalization of compounds—MAOA—conduct disorder	0.0025	0.00614	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—MB21D1—conduct disorder	0.00241	0.00593	CbGpPWpGaD
Flunarizine—CALM3—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00239	0.00588	CbGpPWpGaD
Flunarizine—HRH1—GPCRs, Class A Rhodopsin-like—DRD4—conduct disorder	0.00238	0.00586	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—MB21D1—conduct disorder	0.00233	0.00573	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—MB21D1—conduct disorder	0.00233	0.00573	CbGpPWpGaD
Flunarizine—CALM1—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00231	0.00569	CbGpPWpGaD
Flunarizine—CALM2—Role of Calcineurin-dependent NFAT signaling in lymphocytes—EP300—conduct disorder	0.00231	0.00569	CbGpPWpGaD
Flunarizine—CYP1A2—Phase II conjugation—COMT—conduct disorder	0.00228	0.00562	CbGpPWpGaD
Flunarizine—CYP2B6—Biological oxidations—COMT—conduct disorder	0.00227	0.00558	CbGpPWpGaD
Flunarizine—CYP2B6—Biological oxidations—MAOA—conduct disorder	0.00225	0.00554	CbGpPWpGaD
Flunarizine—CYP2B6—Metapathway biotransformation—COMT—conduct disorder	0.00224	0.0055	CbGpPWpGaD
Flunarizine—CACNA1I—Developmental Biology—EP300—conduct disorder	0.00214	0.00526	CbGpPWpGaD
Flunarizine—CYP1A1—Biological oxidations—COMT—conduct disorder	0.00209	0.00515	CbGpPWpGaD
Flunarizine—CYP1A1—Biological oxidations—MAOA—conduct disorder	0.00208	0.00512	CbGpPWpGaD
Flunarizine—CYP1A1—Metapathway biotransformation—COMT—conduct disorder	0.00206	0.00508	CbGpPWpGaD
Flunarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—DRD4—conduct disorder	0.00204	0.00502	CbGpPWpGaD
Flunarizine—HRH1—G alpha (q) signalling events—HTR2A—conduct disorder	0.00201	0.00494	CbGpPWpGaD
Flunarizine—CALM3—Transmission across Chemical Synapses—COMT—conduct disorder	0.00196	0.00481	CbGpPWpGaD
Flunarizine—CALM3—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00194	0.00478	CbGpPWpGaD
Flunarizine—CALM1—Transmission across Chemical Synapses—COMT—conduct disorder	0.00189	0.00466	CbGpPWpGaD
Flunarizine—CALM2—Transmission across Chemical Synapses—COMT—conduct disorder	0.00189	0.00466	CbGpPWpGaD
Flunarizine—CALM1—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00188	0.00462	CbGpPWpGaD
Flunarizine—CALM2—Transmission across Chemical Synapses—MAOA—conduct disorder	0.00188	0.00462	CbGpPWpGaD
Flunarizine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—conduct disorder	0.0018	0.00442	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00178	0.00438	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—POLR3A—conduct disorder	0.00177	0.00435	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—POLR3A—conduct disorder	0.00171	0.00421	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—POLR3A—conduct disorder	0.00171	0.00421	CbGpPWpGaD
Flunarizine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EP300—conduct disorder	0.00164	0.00405	CbGpPWpGaD
Flunarizine—CYP1A2—Aryl Hydrocarbon Receptor—EP300—conduct disorder	0.00164	0.00405	CbGpPWpGaD
Flunarizine—CYP2D6—Biological oxidations—COMT—conduct disorder	0.00158	0.00388	CbGpPWpGaD
Flunarizine—CACNA1G—Developmental Biology—EP300—conduct disorder	0.00157	0.00388	CbGpPWpGaD
Flunarizine—HRH1—GPCR downstream signaling—CGA—conduct disorder	0.00157	0.00386	CbGpPWpGaD
Flunarizine—CYP2D6—Biological oxidations—MAOA—conduct disorder	0.00156	0.00385	CbGpPWpGaD
Flunarizine—CYP2C9—Biological oxidations—COMT—conduct disorder	0.00156	0.00385	CbGpPWpGaD
Flunarizine—CYP2D6—Metapathway biotransformation—COMT—conduct disorder	0.00155	0.00383	CbGpPWpGaD
Flunarizine—HRH1—GPCRs, Class A Rhodopsin-like—HTR2A—conduct disorder	0.00155	0.00382	CbGpPWpGaD
Flunarizine—HRH1—GPCR ligand binding—DRD4—conduct disorder	0.00155	0.00382	CbGpPWpGaD
Flunarizine—CYP2C9—Biological oxidations—MAOA—conduct disorder	0.00155	0.00382	CbGpPWpGaD
Flunarizine—CYP2C9—Metapathway biotransformation—COMT—conduct disorder	0.00154	0.00379	CbGpPWpGaD
Flunarizine—CACNA1H—Developmental Biology—EP300—conduct disorder	0.00152	0.00375	CbGpPWpGaD
Flunarizine—CALM3—Neuronal System—COMT—conduct disorder	0.0015	0.00369	CbGpPWpGaD
Flunarizine—CALM3—Neuronal System—MAOA—conduct disorder	0.00149	0.00366	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—WASF1—conduct disorder	0.00149	0.00366	CbGpPWpGaD
Flunarizine—CALM2—Neuronal System—COMT—conduct disorder	0.00145	0.00357	CbGpPWpGaD
Flunarizine—CALM1—Neuronal System—COMT—conduct disorder	0.00145	0.00357	CbGpPWpGaD
Flunarizine—CALM1—Neuronal System—MAOA—conduct disorder	0.00144	0.00354	CbGpPWpGaD
Flunarizine—CALM2—Neuronal System—MAOA—conduct disorder	0.00144	0.00354	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—WASF1—conduct disorder	0.00144	0.00354	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—WASF1—conduct disorder	0.00144	0.00354	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—CGA—conduct disorder	0.00142	0.0035	CbGpPWpGaD
Flunarizine—CALM3—Immune System—MB21D1—conduct disorder	0.0014	0.00345	CbGpPWpGaD
Flunarizine—CALM1—Immune System—MB21D1—conduct disorder	0.00136	0.00334	CbGpPWpGaD
Flunarizine—CALM2—Immune System—MB21D1—conduct disorder	0.00136	0.00334	CbGpPWpGaD
Flunarizine—CYP1A2—Biological oxidations—COMT—conduct disorder	0.00133	0.00329	CbGpPWpGaD
Flunarizine—HRH1—Class A/1 (Rhodopsin-like receptors)—HTR2A—conduct disorder	0.00133	0.00327	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00133	0.00327	CbGpPWpGaD
Flunarizine—CYP1A2—Biological oxidations—MAOA—conduct disorder	0.00133	0.00326	CbGpPWpGaD
Flunarizine—CYP1A2—Metapathway biotransformation—COMT—conduct disorder	0.00132	0.00324	CbGpPWpGaD
Flunarizine—CYP1A1—PPARA activates gene expression—EP300—conduct disorder	0.00128	0.00316	CbGpPWpGaD
Flunarizine—CYP1A1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—EP300—conduct disorder	0.00126	0.00309	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—CGA—conduct disorder	0.00118	0.00291	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—CGA—conduct disorder	0.00114	0.00282	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—CGA—conduct disorder	0.00114	0.00282	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism of lipids and lipoproteins—CGA—conduct disorder	0.00114	0.0028	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—CGA—conduct disorder	0.00106	0.00262	CbGpPWpGaD
Flunarizine—CALM3—Immune System—POLR3A—conduct disorder	0.00103	0.00253	CbGpPWpGaD
Flunarizine—HRH1—GPCR ligand binding—HTR2A—conduct disorder	0.00101	0.00249	CbGpPWpGaD
Flunarizine—CALM2—Immune System—POLR3A—conduct disorder	0.000996	0.00245	CbGpPWpGaD
Flunarizine—CALM1—Immune System—POLR3A—conduct disorder	0.000996	0.00245	CbGpPWpGaD
Flunarizine—HRH1—GPCR downstream signaling—DRD4—conduct disorder	0.000877	0.00216	CbGpPWpGaD
Flunarizine—CALM3—Immune System—WASF1—conduct disorder	0.000866	0.00213	CbGpPWpGaD
Flunarizine—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—EP300—conduct disorder	0.000866	0.00213	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—CGA—conduct disorder	0.000859	0.00211	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—CGA—conduct disorder	0.00084	0.00207	CbGpPWpGaD
Flunarizine—CALM2—Immune System—WASF1—conduct disorder	0.000838	0.00206	CbGpPWpGaD
Flunarizine—CALM1—Immune System—WASF1—conduct disorder	0.000838	0.00206	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—CGA—conduct disorder	0.000836	0.00206	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—CGA—conduct disorder	0.000809	0.00199	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—CGA—conduct disorder	0.000809	0.00199	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—DRD4—conduct disorder	0.000796	0.00196	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—CGA—conduct disorder	0.000793	0.00195	CbGpPWpGaD
Flunarizine—CALM3—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000758	0.00187	CbGpPWpGaD
Flunarizine—CALM2—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000733	0.0018	CbGpPWpGaD
Flunarizine—CALM1—RNF mutants show enhanced WNT signaling and proliferation—EP300—conduct disorder	0.000733	0.0018	CbGpPWpGaD
Flunarizine—CALM3—Signaling by WNT in cancer—EP300—conduct disorder	0.000704	0.00173	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—CGA—conduct disorder	0.000699	0.00172	CbGpPWpGaD
Flunarizine—CALM2—Signaling by WNT in cancer—EP300—conduct disorder	0.000681	0.00168	CbGpPWpGaD
Flunarizine—CALM1—Signaling by WNT in cancer—EP300—conduct disorder	0.000681	0.00168	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—CGA—conduct disorder	0.000676	0.00166	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—CGA—conduct disorder	0.000676	0.00166	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—WASF1—conduct disorder	0.000673	0.00166	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—DRD4—conduct disorder	0.000663	0.00163	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—DRD4—conduct disorder	0.000641	0.00158	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—DRD4—conduct disorder	0.000641	0.00158	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—CGA—conduct disorder	0.000597	0.00147	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—CGA—conduct disorder	0.000592	0.00146	CbGpPWpGaD
Flunarizine—CALM3—Signaling by Wnt—EP300—conduct disorder	0.00058	0.00143	CbGpPWpGaD
Flunarizine—HRH1—GPCR downstream signaling—HTR2A—conduct disorder	0.000572	0.00141	CbGpPWpGaD
Flunarizine—CALM2—Signaling by Wnt—EP300—conduct disorder	0.000561	0.00138	CbGpPWpGaD
Flunarizine—CALM1—Signaling by Wnt—EP300—conduct disorder	0.000561	0.00138	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—WASF1—conduct disorder	0.00056	0.00138	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—WASF1—conduct disorder	0.000542	0.00133	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—WASF1—conduct disorder	0.000542	0.00133	CbGpPWpGaD
Flunarizine—HRH1—Signaling by GPCR—HTR2A—conduct disorder	0.00052	0.00128	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—CGA—conduct disorder	0.000506	0.00124	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—COMT—conduct disorder	0.000481	0.00118	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—MAOA—conduct disorder	0.000477	0.00117	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—DRD4—conduct disorder	0.00047	0.00116	CbGpPWpGaD
Flunarizine—CALM3—Signaling by GPCR—HTR2A—conduct disorder	0.000432	0.00106	CbGpPWpGaD
Flunarizine—CALM2—Signaling by GPCR—HTR2A—conduct disorder	0.000418	0.00103	CbGpPWpGaD
Flunarizine—CALM1—Signaling by GPCR—HTR2A—conduct disorder	0.000418	0.00103	CbGpPWpGaD
Flunarizine—CALM3—Hemostasis—EP300—conduct disorder	0.000399	0.000983	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—DRD4—conduct disorder	0.000391	0.000964	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—COMT—conduct disorder	0.000388	0.000954	CbGpPWpGaD
Flunarizine—CALM1—Hemostasis—EP300—conduct disorder	0.000386	0.00095	CbGpPWpGaD
Flunarizine—CALM2—Hemostasis—EP300—conduct disorder	0.000386	0.00095	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—MAOA—conduct disorder	0.000385	0.000948	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—DRD4—conduct disorder	0.000379	0.000932	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—DRD4—conduct disorder	0.000379	0.000932	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—COMT—conduct disorder	0.000377	0.000929	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—MAOA—conduct disorder	0.000375	0.000922	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—COMT—conduct disorder	0.000365	0.000899	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—COMT—conduct disorder	0.000365	0.000899	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—MAOA—conduct disorder	0.000362	0.000892	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—MAOA—conduct disorder	0.000362	0.000892	CbGpPWpGaD
Flunarizine—CALM3—Innate Immune System—EP300—conduct disorder	0.000359	0.000885	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—COMT—conduct disorder	0.000358	0.000881	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—MAOA—conduct disorder	0.000355	0.000875	CbGpPWpGaD
Flunarizine—CALM1—Innate Immune System—EP300—conduct disorder	0.000348	0.000856	CbGpPWpGaD
Flunarizine—CALM2—Innate Immune System—EP300—conduct disorder	0.000348	0.000856	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000345	0.000849	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—HTR2A—conduct disorder	0.000307	0.000756	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—COMT—conduct disorder	0.000269	0.000663	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—MAOA—conduct disorder	0.000268	0.000659	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—COMT—conduct disorder	0.000267	0.000658	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—MAOA—conduct disorder	0.000265	0.000653	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.000257	0.000633	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—HTR2A—conduct disorder	0.000255	0.000629	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—HTR2A—conduct disorder	0.000247	0.000608	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—HTR2A—conduct disorder	0.000247	0.000608	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—COMT—conduct disorder	0.000228	0.000562	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—MAOA—conduct disorder	0.000227	0.000558	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism of lipids and lipoproteins—EP300—conduct disorder	0.00022	0.000541	CbGpPWpGaD
Flunarizine—CALM3—Immune System—EP300—conduct disorder	0.000209	0.000515	CbGpPWpGaD
Flunarizine—CYP2A6—Metabolism—EP300—conduct disorder	0.000206	0.000507	CbGpPWpGaD
Flunarizine—CALM2—Immune System—EP300—conduct disorder	0.000202	0.000498	CbGpPWpGaD
Flunarizine—CALM1—Immune System—EP300—conduct disorder	0.000202	0.000498	CbGpPWpGaD
Flunarizine—CALM3—Disease—EP300—conduct disorder	0.000193	0.000476	CbGpPWpGaD
Flunarizine—CALM2—Disease—EP300—conduct disorder	0.000187	0.00046	CbGpPWpGaD
Flunarizine—CALM1—Disease—EP300—conduct disorder	0.000187	0.00046	CbGpPWpGaD
Flunarizine—CYP2B6—Metabolism—EP300—conduct disorder	0.000166	0.000409	CbGpPWpGaD
Flunarizine—HRH1—Signaling Pathways—EP300—conduct disorder	0.000163	0.0004	CbGpPWpGaD
Flunarizine—CALM3—Metabolism—EP300—conduct disorder	0.000162	0.000398	CbGpPWpGaD
Flunarizine—CALM1—Metabolism—EP300—conduct disorder	0.000157	0.000385	CbGpPWpGaD
Flunarizine—CALM2—Metabolism—EP300—conduct disorder	0.000157	0.000385	CbGpPWpGaD
Flunarizine—CYP1A1—Metabolism—EP300—conduct disorder	0.000154	0.000378	CbGpPWpGaD
Flunarizine—CALM3—Signaling Pathways—EP300—conduct disorder	0.000135	0.000333	CbGpPWpGaD
Flunarizine—CALM1—Signaling Pathways—EP300—conduct disorder	0.000131	0.000322	CbGpPWpGaD
Flunarizine—CALM2—Signaling Pathways—EP300—conduct disorder	0.000131	0.000322	CbGpPWpGaD
Flunarizine—CYP2D6—Metabolism—EP300—conduct disorder	0.000116	0.000284	CbGpPWpGaD
Flunarizine—CYP2C9—Metabolism—EP300—conduct disorder	0.000115	0.000282	CbGpPWpGaD
Flunarizine—CYP1A2—Metabolism—EP300—conduct disorder	9.79e-05	0.000241	CbGpPWpGaD
